PHOENIX, Ariz., Feb. 1, 2023 /PRNewswire/ — 1606 Corp (OTC: CBDW), an acquisition-based CBD + Hemp retail product distribution company, announces that the company’s products are sold in retail locations in the United States. 1606 products are now actively engaged in a modern direct marketing campaign to continue the growth into individual retail stores and have hired a direct marketing industry veteran, Brent Duskin. Mr. Duskin has worked with fortune 500 companies that complement CEO Greg Lambrecht’s experience and connections in retail distribution. Mr. Lambrecht has personally conducted business with over 30,000 retail stores in his career and is the foundation of the recent growth of 1606 CBD products.

The company’s main product skew is CBD SINGLZ, which is a smokable CDB product. The displays hold three 25ct Singlz containing mango-flavored CBD rolls, Original Flavor, and Menthol. These products are enthusiastically being used by cigarette smokers to quit their addiction to nicotine. 1606 Corp currently has enough inventory to fill orders for an additional 2500 retail locations.

“The gap left as a result of the flavor ban on vaping and tobacco products has left a lot of shelves open, so we’re aggressively taking advantage of that opportunity,” said CEO and Chairman – Greg Lambrecht.

CEO & Chairman of the Board – Greg Lambrecht
Visionary entrepreneur backed by a robust tenure in company operations, investor relations, and corporate leadership, has a successful track record in founding and leading start-up companies. As the founder of PCI, a leading consumer product distribution company, Greg negotiated agreements with the nation’s largest retail outlets such as 7-11 (Southland Corp), Albertson’s, and Costco representing 25,000 retail accounts. Greg led PCI through a NASDAQ-listed IPO, raising $10,000,000. Greg is a graduate of Western Washington University with a degree in marketing communications.

Since taking PCI public several years ago, Greg completed a reverse merger in 2011 into a company now called Singlepoint. Greg resigned as Chairman/CEO/Director and spun out 1606 Corp (Doing Business AS CBD.INC (OTC | CBDW) is a public company from Singlepoint. Greg has now taken three companies public, raising millions of dollars in the process.

About Brent Duskin;
Brent’s expertise includes direct marketing strategic planning, offer development, platform testing, and rollout. Brent has worked on, developed, and created well over 10,000 new customer lead generation and acquisitions programs for companies such as Time Warner Cable, AT&T & Fisher Investments.

Brent’s portfolio includes examples of joint-agency direct marketing campaign collaborations where he developed offline awareness and fulfillment campaigns that included brands such as: Kevin O’Leary, Robert Herjavec, Barbara Corcoran from “Shark Tank”, Scott McGillivray of “Income Properties”, Jonathan & Drew Scott, AKA “The Property Brothers”, Scott & Amie Yancey of “Flipping Vegas”, Josh Altman from “Million Dollar Listings LA”, Scott Disick of “Flip it Like Disick”, Dean Graziosi, “The Millionaire Mentor”, and many others.

About 1606 Corp;
1606 Corp acquires and develops CBD brands including Truz and CBD Singlez, (www.1606hemp.com). The company utilizes an acquisition model aimed at consolidating the fragmented CBD industry. 1606 Corp has a primary focus on Hemp and CBD products, brand development, and establishing distribution channels. 1606 Corp. was awarded the ticker symbol CBDW on January 12th, 2022, and began trading on the OTC Market on January 17th, 2023.

Industry Information;
The Cannabidiol (CBD) market accounted for USD 12.8 billion in 2021 and is estimated to grow with a 21.7% CAGR between 2022 and 2028, according to Grand view research (link). The global cannabidiol (CBD) market size was valued at $5.18 billion in 2021 and is expected to expand, at a compounded annual growth rate (CAGR) of 16.8% from 2022 to 2030. Cannabidiol (CBD) is a chemical compound that is found in the cannabis Sativa plant, and is extracted from hemp or cannabis, generally from hemp due to its naturally high cannabidiol (CBD) content…

Forward-Looking Statements
This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief, or current expectations of 1606 Corp (the “Company”), its directors, or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will materially affect actual results, levels of activity, performance, or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

Contact:
Greg Lambrecht
[email protected]
CBD.inc

Austen Lambrecht
[email protected]
CBD.inc
888-223-9510

Company Websites;
www.1606hemp.com
www.CBD.Inc

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

KINGSVILLE, Ontario – December 1, 2022 – Greenway Greenhouse Cannabis Corporation (CSE:GWAY) (OTCQB: GWAYF) (“Greenway Greenhouse” or the “Company”) a cultivator of high-quality greenhouse cannabis for the Canadian market, is pleased to announce that it has been approved to commence trading of its common shares on the OTCQB^® Venture Market (“OTCQB”), beginning today, December 1, 2022, under the ticker symbol GWAYF.

“We are please to offer investors yet another avenue for trading our shares, one that will increase awareness around our company to U.S based investors. The OTCQB^® Venture Market is one of the most respected and professional marketplaces in the world, and Greenway is pleased to be a part of it,” said Jamie D’Alimonte, CEO of Greenway. “Trading on the OTCQB^® will lead to enhanced liquidity and visibility in these shifting and dynamic global capital markets.”

“GWAYF being listed on the OTCQB^® Venture Market is an important milestone for Greenway, as this helps grow our U.S investor base and will help enlighten American investors to both our company and story,” said Darren Peddle, CFO of Greenway. “At its core, we believe this will provide improved liquidity, which should enhance shareholder value.”

The Company’s common shares will continue to trade on the Canadian Securities Exchange (“CSE”) under the symbol GWAY.

Investors can find real-time quotes and market information for the Company at:

GWAYF – Greenway Greenhouse Cannabis Corporation | Quote | OTC Markets

About Greenway

Greenway Greenhouse Cannabis Corporation is a federally licensed cultivator for the Canadian cannabis marketplace. Greenway is headquartered in Kingsville, Ontario, and leverages its agriculture and cannabis expertise in its aspiration to be a leading cannabis cultivator in Canada. More information can be found on Greenway.ca and updates can be followed on Instagram, Twitter, Facebook, and LinkedIn.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX^® Best Market, OTCQB^® Venture Market and Pink^® Open Market.

Our OTC Link^® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.

OTC Link ATS, OTC Link ECN and OTC Link NQB are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

Subscribe to the OTC Markets RSS Feed

The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

Contact Information

Investor Contact

Sam Nehmetallah

Greenway Greenhouse Cannabis Corporation

[email protected]

1-519-819-5145

Company Contact

Darren Peddle, Director and CFO

Greenway Greenhouse Cannabis Corporation

[email protected]

1-519-712-0311

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements that constitute forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding the Offering and the intended use of proceeds thereof, and the Company’s beliefs, plans, expectations, future, strategy, objectives, goals and targets, the development of future operations, and orientations regarding the future as of the date of this news release. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: “believes”, “expects”, “aim”, “anticipates”, “intends”, “estimates”, “plans”, “may”, “should”, “would”, “will”, “potential”, “scheduled” or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved.

Forward-looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements, and includes those risks described in the Company’s final prospectus dated September 3, 2021, a copy of which is available under the Company’s profile at www.sedar.com. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements.

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>

<!– Click –>

Charlotte’s Web Holdings Inc. (TSX: CWEB) bought Abacus Health Products Inc. in a stock transaction worth about $100 million last June. With competition on the rise in the CBD industry, Abacus provided Charlotte’s Web with a portfolio of over-the-counter (OTC) topical products that combined active pharmaceutical ingredients with hemp extracts.

HempFusion Inc. (TSX: CBD.U – reserved) has taken a similar approach with its portfolio of proprietary OTC FDA Drug Listed topical products. By going through the lengthy and costly approval process, the company can make unique health claims that differentiate its products including: pain relief, eczema relief and acne relief.

Click here to receive an investor presentation and IPO alert

Unique Product Portfolio

HempFusion Co-Founder and CEO Jason Mitchell, N.D. was instrumental in building Country Life Vitamins, a leader in health and wellness supplements, as Chief Science Officer. Building upon that experience, he co-founded HempFusion and Probulin to focus on next-generation probiotic supplements and unlocking the promise of phytocannabinoids like CBD.

After several years and over $2 million in capital investment, Mitchell helped secure OTC Drug Listed status for its line of topical CBD products targeting pain relief, wound healing, anti-aging, and other categories. The company’s other products include proprietary blends designed to support healthy sleep, promote energy and reduce anxiety.

Charlotte’s Web’s acquisition of Abacus Health underscores the uniqueness of the ability to make these claims. After all, most CBD companies don’t have the time or capital required to advance products through the years-long and multi-million-dollar process of securing FDA OTC Drug Listed status for their product lines; and therefore, cannot make impactful health claims. 

The company’s OTC Drug Listed portfolio provides both a competitive barrier to entry and an important marketing advantage on store shelves. In addition to these qualities, the company has already built robust distribution channels, including Amazon.com, Whole Foods, Sprouts and the Vitamin Shoppe with plans to move into Big Box (Food & Drug Mass) and convenience stores soon.

Click here to receive an investor presentation and IPO alert

IPO on a Senior Exchange

HempFusion plans to complete its Initial Public Offering on Canada’s Toronto Stock Exchange (TSX) in December. After setting out to raise $17 million, the company immediately saw a heavily oversubscribed order book with interest from both accredited investors in the United States and non-accredited investors in Canada.

With the second largest cash position in the industry at about $18 million as of June 2020, the company’s $17 million capital raise will provide ample capital to pursue its ambitious plans to reach 150,000 retail locations over time. Its focus on ecommerce could further help it dominate a space that has seen record levels of consumer interest.

The Brightfield Group projects that the U.S. CBD market will reach $16.8 billion by 2025. The company believes that the growth will reward companies that react quickly to the market and ultimately unlock significant value.

Looking Ahead

HempFusion is well positioned to capitalize on growing demand for CBD products. With OTC Drug Listed status, it has a unique marketing advantage compared to other products that have become ubiquitous on store shelves. The funding from its IPO should help expand its distribution and revenue over the coming quarters. 

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.